GLP-1 Weight Loss Drugs May Lower the Risk for 14 Obesity-Related Cancers
A new study finds women taking GLP-1 Receptor agonists were significantly less likely to develop obesity-related cancers.
Health News is provided as a service to Bach Pharmacy | North site users by HealthDay. Bach Pharmacy | North nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.